Trafalgar International (OTCMKTS:GCAN – Get Free Report)’s stock price fell 26.6% on Tuesday. The stock traded as low as $0.80 and last traded at $0.80. 1,617 shares were traded during trading, a decline of 80% from the average daily volume of 8,036 shares. The stock had previously closed at $1.09.
Trafalgar International Trading Down 7.4%
The business has a fifty day simple moving average of $1.40 and a 200 day simple moving average of $1.09.
About Trafalgar International
The Greater Cannabis Company, Inc, a biopharmaceutical company, focuses on the development and commercialization of technology for transmucosal delivery of legal medical or recreational cannabis and cannabinoids. It intends to commercialize the technology by sublicensing or partnering with licensed producers, distributors, processors, consumer product, and pharmaceutical companies. The company was founded in 2014 and is based in Baltimore, Maryland.
Recommended Stories
- Five stocks we like better than Trafalgar International
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for Trafalgar International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trafalgar International and related companies with MarketBeat.com's FREE daily email newsletter.
